Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
- PMID: 10097104
- PMCID: PMC22361
- DOI: 10.1073/pnas.96.7.3723
Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
Abstract
Human fibroblasts whose lifespan in culture has been extended by expression of a viral oncogene eventually undergo a growth crisis marked by failure to proliferate. It has been proposed that telomere shortening in these cells is the property that limits their proliferation. Here we report that ectopic expression of the wild-type reverse transcriptase protein (hTERT) of human telomerase averts crisis, at the same time reducing the frequency of dicentric and abnormal chromosomes. Surprisingly, as the resulting immortalized cells containing active telomerase continue to proliferate, their telomeres continue to shorten to mean lengths below those in control cells that enter crisis. These results provide evidence for a protective function of human telomerase that allows cell proliferation without requiring net lengthening of telomeres.
Figures





Comment in
-
Crisis intervention: the role of telomerase.Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3339-41. doi: 10.1073/pnas.96.7.3339. Proc Natl Acad Sci U S A. 1999. PMID: 10097039 Free PMC article. Review. No abstract available.
Similar articles
-
Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.Oncogene. 1999 Jul 22;18(29):4211-23. doi: 10.1038/sj.onc.1202797. Oncogene. 1999. PMID: 10435634
-
Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells.Exp Cell Res. 2001 May 1;265(2):304-11. doi: 10.1006/excr.2001.5189. Exp Cell Res. 2001. PMID: 11302696
-
Catalytically active human telomerase mutants with allele-specific biological properties.Exp Cell Res. 2003 Aug 15;288(2):277-87. doi: 10.1016/s0014-4827(03)00217-9. Exp Cell Res. 2003. PMID: 12915119
-
Telomere dynamics and telomerase activity in in vitro immortalised human cells.Eur J Cancer. 1997 Apr;33(5):767-73. doi: 10.1016/S0959-8049(97)00065-8. Eur J Cancer. 1997. PMID: 9282115 Review.
-
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14. J Biomed Mater Res A. 2015. PMID: 26034007 Review.
Cited by
-
Immortalization of a primate bipotent epithelial liver stem cell.Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3639-44. doi: 10.1073/pnas.062038599. Proc Natl Acad Sci U S A. 2002. PMID: 11904425 Free PMC article.
-
Mediterranean diet, telomere maintenance and health status among elderly.PLoS One. 2013 Apr 30;8(4):e62781. doi: 10.1371/journal.pone.0062781. Print 2013. PLoS One. 2013. PMID: 23646142 Free PMC article.
-
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7982-7. doi: 10.1073/pnas.131211098. Proc Natl Acad Sci U S A. 2001. PMID: 11438744 Free PMC article.
-
Telomerase promotes formation of a telomere protective complex in cancer cells.Sci Adv. 2019 Oct 2;5(10):eaav4409. doi: 10.1126/sciadv.aav4409. eCollection 2019 Oct. Sci Adv. 2019. PMID: 31616780 Free PMC article.
-
A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice.Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10173-8. doi: 10.1073/pnas.0803559105. Epub 2008 Jul 14. Proc Natl Acad Sci U S A. 2008. PMID: 18626023 Free PMC article.
References
-
- Hayflick L, Moorhead P S. Exp Cell Res. 1961;25:585–621. - PubMed
-
- Shay J W, Pereira-Smith O M, Wright W E. Exp Cell Res. 1991;196:33–39. - PubMed
-
- Hara E, Tsurui H, Shinozaki A, Nakada S, Oda K. Biochem Biophys Res Commun. 1991;179:528–534. - PubMed
-
- Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y, Shinkai Y. Nat Genet. 1998;19:203–206. - PubMed
-
- McEachern M J, Blackburn E H. Genes Dev. 1996;10:1822–1834. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources